Marco Luoni
Impact in
-
- Colorectal Cancer Treatments and Studies
-
- Bladder and Urothelial Cancer Treatments
Papers in
-
- Lymphoma Diagnosis and Treatment 5
-
- Drug-Induced Hepatotoxicity and Protection 1
- Co-authors
- S. Fava (6 shared papers)Antonino De Paoli (4 shared papers)Renzo Luciano Boldorini (1 shared paper)Stefano Crippa (1 shared paper)Oscar Alabiso (1 shared paper)Sara Malatesta (1 shared paper)Milo Frattini (1 shared paper)Lara Felicioni (1 shared paper)
- Journals
- Annals of Oncology (2 papers)Clinical Cancer Research (1 paper)Journal of Clinical Oncology (1 paper)Chemotherapy (1 paper)Tumori Journal (2 papers)
- Partner nations
- ItalySwitzerland
In The Last Decade
Marco Luoni
12 papers receiving 467 citations
Peers
Comparison fields: 5 of 39
- Oncology 109
- Surgery 172
- Pathology and Forensic Medicine 67
- Cancer Research 40
- Genetics 22
Countries citing papers authored by Marco Luoni
This map shows the geographic impact of Marco Luoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Luoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Luoni more than expected).
Fields of papers citing papers by Marco Luoni
This network shows the impact of papers produced by Marco Luoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Luoni. The network helps show where Marco Luoni may publish in the future.
Co-authors
The 25 scholars most cited alongside Marco Luoni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 173 | |
| 2 | 2011 | 144 | |
| 3 | Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma. | 1997 | 49 |
| 4 | 2000 | 33 | |
| 5 | A cooperative study of epirubicin with cyclophosphamide, vincristine and prednisone (CEOP) in non-Hodgkin's lymphoma. | 1995 | 21 |
| 6 | Undifferentiated granulocytic sarcoma: a case with epidural onset preceding acute promyelocytic leukemia. | 1995 | 13 |
| 7 | Retroperitoneal hemorrhage following bone marrow biopsy. | 2004 | 13 |
| 8 | 1995 | 12 | |
| 9 | Idiopathic hypereosinophilic syndrome and "eosinophilic leukemia". | 1993 | 11 |
| 10 | 1996 | 9 | |
| 11 | Pericarditis during interferon-alpha therapy in chronic myelogenous leukemia. | 1997 | 8 |
| 12 | 2007 | 1 | |
| 13 | 2017 | 0 |
About Marco Luoni
Marco Luoni is a scholar working on Pathology and Forensic Medicine, Pharmacology, Oncology, Occupational Therapy and Emergency Medicine, having authored 13 papers that have together received 487 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (1 paper), Case Reports on Hematomas (1 paper), Hepatitis B Virus Studies (1 paper), Acute Myeloid Leukemia Research (1 paper), Safe Handling of Antineoplastic Drugs (1 paper), Drug-Induced Hepatotoxicity and Protection (1 paper) and Pericarditis and Cardiac Tamponade (1 paper). The work is most often cited by research in Oncology (109 citations), Surgery (172 citations), Pathology and Forensic Medicine (67 citations), Cancer Research (40 citations) and Genetics (22 citations). Marco Luoni has collaborated with scholars based in Italy and Switzerland. Frequent co-authors include S. Fava, Antonino De Paoli, Renzo Luciano Boldorini, Stefano Crippa, Oscar Alabiso, Sara Malatesta, Milo Frattini, Lara Felicioni, Francesca Molinari and Sara De Dosso. Their work appears in journals such as Annals of Oncology, Clinical Cancer Research, Journal of Clinical Oncology, Chemotherapy and Tumori Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.